{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T00:27:50Z","timestamp":1791764870163,"version":"4.3.4"},"reference-count":162,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T00:00:00Z","timestamp":1748304000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Br J Clin Pharmacol"],"published-print":{"date-parts":[[2025,8]]},"abstract":"<jats:p>Climate change\u2014the global crisis with pervasive health impacts\u2014has adverse consequences for people with epilepsy (PWE) who have low quality of life due to poor seizure control, socioeconomic disadvantages and comorbidities. This review focuses on the potential effects of climate change on the pharmacological characteristics of antiseizure medications (ASMs), antipsychotics and antidepressants. We note that findings particularly obtained from physicochemical stability studies have been demonstrated experimentally for some specific environmental conditions whereas studies for clinical outcome effects are very limited. Carbamazepine, valproate, phenytoin or lorazepam appear to be ASMs at risk of being affected by high temperature and\/or humidity. Even the stability of blood samples needs to be considered during transportation to therapeutic drug monitoring units, particularly for the PWE living in low\u2010income countries that are facing the most challenges of climate change effects attributed to low infrastructure and healthcare system capacity. We need more urgent research investigating drug responses of PWE regarding especially the effects of adverse weather events such as heatwaves on physicochemical stability or pharmacokinetics of drugs in a complex interaction with the vulnerabilities of individuals, accompanying neuropsychiatric disorders and geographical challenges. Then we will be able to develop pharmacological treatment strategies to improve the quality of life of PWE during adverse weather events.<\/jats:p>","DOI":"10.1002\/bcp.70108","type":"journal-article","created":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T00:54:06Z","timestamp":1748393646000},"page":"2205-2221","source":"Crossref","is-referenced-by-count":17,"title":["Medications, epilepsy and climate change: Added layers of complexity"],"prefix":"10.1002","volume":"91","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4894-9867","authenticated-orcid":false,"given":"Medine I.","family":"Gulcebi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology  London UK"},{"name":"Chalfont Centre for Epilepsy  Chalfont St Peter UK"},{"name":"Department of Medical Pharmacology Marmara University School of Medicine  Istanbul Turkey"},{"name":"Epilepsy Research and Implementation Centre (EPAM), Marmara University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyhmus","family":"Gavas","sequence":"additional","affiliation":[{"name":"Department of Medical Pharmacology Marmara University School of Medicine  Istanbul Turkey"},{"name":"Epilepsy Research and Implementation Centre (EPAM), Marmara University  Istanbul Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay M.","family":"Sisodiya","sequence":"additional","affiliation":[{"name":"Department of Clinical and Experimental Epilepsy UCL Queen Square Institute of Neurology  London UK"},{"name":"Chalfont Centre for Epilepsy  Chalfont St Peter UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2025,5,27]]},"reference":[{"key":"e_1_2_11_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(06)68079\u20103"},{"key":"e_1_2_11_3_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.2307"},{"key":"e_1_2_11_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468\u20101331.2009.02581.x"},{"key":"e_1_2_11_5_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19106123"},{"key":"e_1_2_11_6_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev\u2010publhealth\u2010012420\u2010105026"},{"key":"e_1_2_11_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1098704"},{"key":"e_1_2_11_8_1","doi-asserted-by":"publisher","DOI":"10.1080\/10903127.2016.1258098"},{"key":"e_1_2_11_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(21)01208\u20103"},{"key":"e_1_2_11_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41591\u2010024\u201003186\u20101"},{"key":"e_1_2_11_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2021.107791"},{"key":"e_1_2_11_12_1","doi-asserted-by":"publisher","DOI":"10.31487\/j.NNB.2020.02.03"},{"key":"e_1_2_11_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/braincomms\/fcae269"},{"key":"e_1_2_11_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2023.107164"},{"key":"e_1_2_11_15_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12883\u2010021\u201002535\u20108"},{"key":"e_1_2_11_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/epi4.12359"},{"key":"e_1_2_11_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41582\u2010024\u201001055\u20106"},{"key":"e_1_2_11_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep31879"},{"key":"e_1_2_11_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(18)30454\u2010X"},{"key":"e_1_2_11_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(12)61381\u20106"},{"key":"e_1_2_11_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2023.163032"},{"key":"e_1_2_11_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2024.101081"},{"key":"e_1_2_11_23_1","unstructured":"Chen C. Noble I. Hellmann J. Coffee J. Murillo M. Chawla N.2015.University of Notre Dame Global Adaptation Index country index technical report. nd_gain_countryindextechreport_2023_01.pdf"},{"key":"e_1_2_11_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(18)30499\u2010X"},{"key":"e_1_2_11_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.17112"},{"key":"e_1_2_11_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2018.2410.1038\/nrdp.2018.24"},{"key":"e_1_2_11_27_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40263\u2010021\u201000827\u20108"},{"key":"e_1_2_11_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0013\u20109580.2004.17504.x"},{"key":"e_1_2_11_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2012.03528.x"},{"key":"e_1_2_11_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(15)00225\u20102"},{"key":"e_1_2_11_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40272\u2010020\u201000428\u2010w"},{"key":"e_1_2_11_32_1","doi-asserted-by":"publisher","DOI":"10.1097\/ACM.0000000000003719"},{"key":"e_1_2_11_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2016.01.005"},{"key":"e_1_2_11_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebr.2023.100592"},{"key":"e_1_2_11_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.14015"},{"key":"e_1_2_11_36_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S154388"},{"key":"e_1_2_11_37_1","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2009.24.1.1"},{"key":"e_1_2_11_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2008.06.001"},{"key":"e_1_2_11_39_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.90"},{"key":"e_1_2_11_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101167.2008.01561.x"},{"key":"e_1_2_11_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2004.05.011"},{"key":"e_1_2_11_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1528\u20101157.1993.tb02140.x"},{"key":"e_1_2_11_43_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1985.04060020030009"},{"key":"e_1_2_11_44_1","first-page":"335","volume-title":"Separation science and technology","author":"Wong AW","year":"2005"},{"key":"e_1_2_11_45_1","doi-asserted-by":"publisher","DOI":"10.1093\/chromsci\/bmac070"},{"key":"e_1_2_11_46_1","volume-title":"Strength and stability testing for compounded preparations","author":"USP Compounding Expert Committee","year":"2014"},{"key":"e_1_2_11_47_1","doi-asserted-by":"publisher","DOI":"10.1208\/s12248\u2010015\u20109834\u20105"},{"key":"e_1_2_11_48_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14020325"},{"key":"e_1_2_11_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2013.04.018"},{"key":"e_1_2_11_50_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175208"},{"key":"e_1_2_11_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0735\u20106757(99)90079\u20107"},{"key":"e_1_2_11_52_1","doi-asserted-by":"publisher","DOI":"10.1081\/ddc\u2010100102163"},{"issue":"10","key":"e_1_2_11_53_1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1002\/jps.2600821004","article-title":"Effects of humidity and temperature on in vitro dissolution of carbamazepine tablets","volume":"82","author":"Wang JT","year":"1993","journal-title":"J Pharm Sci"},{"key":"e_1_2_11_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11095\u2010020\u201002984\u20109"},{"key":"e_1_2_11_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/anatox\/35.8.583"},{"key":"e_1_2_11_56_1","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2017.1297927"},{"key":"e_1_2_11_57_1","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp130189"},{"key":"e_1_2_11_58_1","doi-asserted-by":"publisher","DOI":"10.3109\/10903127.2012.722177"},{"key":"e_1_2_11_59_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpharm.2018.07.042"},{"key":"e_1_2_11_60_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410070218"},{"key":"e_1_2_11_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2015.07.007"},{"key":"e_1_2_11_62_1","doi-asserted-by":"publisher","DOI":"10.1211\/jpp.62.05.0004"},{"issue":"4","key":"e_1_2_11_63_1","first-page":"339","article-title":"Stability of acetazolamide, baclofen, dipyridamole, mebeverine hydrochloride, propylthiouracil, quinidine sulfate, and topiramate oral suspensions in SyrSpend SF PH4","volume":"21","author":"Ferreira AO","year":"2017","journal-title":"Int J Pharmaceut Compound"},{"key":"e_1_2_11_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eplepsyres.2008.03.006"},{"key":"e_1_2_11_65_1","unstructured":"Medicines and Healthcare products Regulatory Agency (MHRA).Antiepileptic drugs: updated advice on switching between different manufacturers' products.2017. Accessed September 20 2024.https:\/\/www.gov.uk\/drug-safety-update\/antiepileptic-drugs-updated-advice-on-switching-between-different-manufacturers-products"},{"key":"e_1_2_11_66_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12889\u2010021\u201011100\u20104"},{"key":"e_1_2_11_67_1","unstructured":"ICH.2003International council for harmonisation of technical requirements of pharmaceuticals for human use (ICH) Q1R2 stability testing new drug substances and products step 5 (2003).https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-q-1-r2-stability-testing-new-drug-substances-and-products-step-5_en.pdf"},{"key":"e_1_2_11_68_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14112324"},{"key":"e_1_2_11_69_1","unstructured":"National Institute of Health (NIH) PubChem.2024. Accessed July 11 2024.https:\/\/pubchem.ncbi.nlm.nih.gov"},{"key":"e_1_2_11_70_1","doi-asserted-by":"publisher","DOI":"10.1310\/hpj4902\u2010136"},{"key":"e_1_2_11_71_1","doi-asserted-by":"publisher","DOI":"10.1177\/0018578719844699"},{"key":"e_1_2_11_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102710.2009.01129.x"},{"key":"e_1_2_11_73_1","first-page":"75","article-title":"How stable are medicines moved from original packs into compliance aids?","volume":"276","author":"Church C","year":"2006","journal-title":"Pharm J"},{"key":"e_1_2_11_74_1","doi-asserted-by":"publisher","DOI":"10.1093\/ijpp\/riac001"},{"key":"e_1_2_11_75_1","doi-asserted-by":"publisher","DOI":"10.1590\/2237\u20106089\u20102015\u20100066"},{"key":"e_1_2_11_76_1","doi-asserted-by":"publisher","DOI":"10.1177\/0269881104040250"},{"key":"e_1_2_11_77_1","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.18651"},{"key":"e_1_2_11_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2013.01.005"},{"key":"e_1_2_11_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2013.07.013"},{"key":"e_1_2_11_80_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13256\u2010023\u201004307\u2010z"},{"key":"e_1_2_11_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2005.12.010"},{"key":"e_1_2_11_82_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691\u2010200408000\u201000019"},{"key":"e_1_2_11_83_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691\u2010199410000\u201000008"},{"key":"e_1_2_11_84_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007691\u2010199001000\u201000016"},{"key":"e_1_2_11_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0009\u20108981(86)90039\u20102"},{"key":"e_1_2_11_86_1","doi-asserted-by":"publisher","DOI":"10.1080\/17425255.2021.1859478"},{"issue":"9","key":"e_1_2_11_87_1","first-page":"66","article-title":"To determine the effect of storage temperature on the stability of serum analytes","volume":"7","author":"Gohel P","year":"2023","journal-title":"Int J Mod Pharm Res"},{"key":"e_1_2_11_88_1","unstructured":"Neoteryx.What is the shelf life and journey of a blood sample? 2024. Accessed December 20 2024.https:\/\/www.neoteryx.com\/microsampling-blog\/what-is-the-shelf-life-of-blood-and-journey-of-a-blood-sample"},{"key":"e_1_2_11_89_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijpx.2021.100106"},{"key":"e_1_2_11_90_1","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600630903"},{"key":"e_1_2_11_91_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088\u2010199834040\u201000004"},{"issue":"11","key":"e_1_2_11_92_1","first-page":"34","article-title":"Season fluctuations of carbamazepine and valproate concentration in patients with epilepsy","volume":"113","author":"Avakian GN","year":"2013","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"key":"e_1_2_11_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/0306\u20109877(82)90037\u20108"},{"key":"e_1_2_11_94_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600\u20100404.1978.tb02879.x"},{"key":"e_1_2_11_95_1","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics13020181"},{"key":"e_1_2_11_96_1","doi-asserted-by":"publisher","DOI":"10.1124\/dmd.111.038125"},{"key":"e_1_2_11_97_1","doi-asserted-by":"publisher","DOI":"10.1124\/mol.51.5.741"},{"key":"e_1_2_11_98_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365\u20102710.1999.00247.x"},{"key":"e_1_2_11_99_1","doi-asserted-by":"publisher","DOI":"10.1139\/y11\u2010030"},{"key":"e_1_2_11_100_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2542\u20105196(24)00026\u20103"},{"key":"e_1_2_11_101_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2005.12.009"},{"key":"e_1_2_11_102_1","doi-asserted-by":"publisher","DOI":"10.1016\/B978\u20100\u20107020\u20104086\u20103.00027\u20108"},{"key":"e_1_2_11_103_1","doi-asserted-by":"publisher","DOI":"10.3390\/ph3061909"},{"key":"e_1_2_11_104_1","doi-asserted-by":"publisher","DOI":"10.1289\/EHP13254"},{"key":"e_1_2_11_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.1284"},{"key":"e_1_2_11_106_1","doi-asserted-by":"publisher","DOI":"10.1097\/00007611\u2010200295080\u201000006"},{"key":"e_1_2_11_107_1","doi-asserted-by":"publisher","DOI":"10.1177\/08830738030180041001"},{"key":"e_1_2_11_108_1","doi-asserted-by":"publisher","DOI":"10.33588\/rn.3402.2001374"},{"key":"e_1_2_11_109_1","unstructured":"Centers for Disease Control and Prevention (CDC).Heat health heat and medications guidance for clinicians.2024. Accessed July 11 2024.https:\/\/www.cdc.gov\/heat-health\/hcp\/heat-and-medications-guidance-for-clinicians.html"},{"key":"e_1_2_11_110_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.12.2015"},{"key":"e_1_2_11_111_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajp.2010.09.002"},{"key":"e_1_2_11_112_1","unstructured":"LAREB (Netherlands Pharmacovigilance Centre).Lamotrigine and photosensitivity.2020Retrieved from FilePreview (lareb.nl)"},{"key":"e_1_2_11_113_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467\u2010842x.2000.tb00531.x"},{"key":"e_1_2_11_114_1","doi-asserted-by":"publisher","DOI":"10.1159\/000503831"},{"key":"e_1_2_11_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2016.11.032"},{"key":"e_1_2_11_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2007.12.019"},{"key":"e_1_2_11_117_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.14445"},{"key":"e_1_2_11_118_1","doi-asserted-by":"publisher","DOI":"10.12688\/wellcomeopenres.16749.2"},{"key":"e_1_2_11_119_1","unstructured":"Worldbank (2024). Accessed September 24 2024.https:\/\/datahelpdesk.worldbank.org\/knowledgebase\/articles\/906519-world-bank-country-and-lending-groups"},{"key":"e_1_2_11_120_1","doi-asserted-by":"publisher","DOI":"10.4102\/safp.v58i4.5443"},{"issue":"2","key":"e_1_2_11_121_1","article-title":"Patterns of antiepileptic drug use and seizure control among people with epilepsy in a suburban community in Southeast Nigeria","volume":"31","author":"Nwani P","year":"2012","journal-title":"Afr J Neurol Sci"},{"issue":"3","key":"e_1_2_11_122_1","first-page":"47","article-title":"Epilepsy in Pakistan: national guidelines for clinicians","volume":"10","author":"Siddiqui F","year":"2015","journal-title":"Pak J Neurol Sci"},{"key":"e_1_2_11_123_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528\u20101157.42.s8.8.x"},{"key":"e_1_2_11_124_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1445\u20105994.1995.tb02822.x"},{"key":"e_1_2_11_125_1","unstructured":"KaneSPClinCalc DrugStats database(version 2024.08). ClinCalc2024. Accessed March 26 2025.https:\/\/clincalc.com\/DrugStats"},{"key":"e_1_2_11_126_1","volume-title":"Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures","author":"EMA (European Medicines Agency)","year":"2024"},{"key":"e_1_2_11_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph15091806"},{"key":"e_1_2_11_128_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0243665"},{"key":"e_1_2_11_129_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474\u20104422(24)00087\u20105"},{"key":"e_1_2_11_130_1","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/8306154"},{"key":"e_1_2_11_131_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002018\u2010200831020\u201000002"},{"key":"e_1_2_11_132_1","doi-asserted-by":"publisher","DOI":"10.1097\/00044067\u2010200404000\u201000010"},{"key":"e_1_2_11_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2007.03.007"},{"key":"e_1_2_11_134_1","doi-asserted-by":"publisher","DOI":"10.1024\/1422\u20104917\/a000484"},{"key":"e_1_2_11_135_1","doi-asserted-by":"publisher","DOI":"10.9740\/mhc.2021.09.301"},{"key":"e_1_2_11_136_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.46.2.183"},{"key":"e_1_2_11_137_1","volume-title":"Practical guidelines for the use of medications with anticholinergic activity and benztropine in adult individuals with intellectual disabilities","author":"Leon J","year":"2011"},{"key":"e_1_2_11_138_1","doi-asserted-by":"crossref","unstructured":"GOV.UK.Hyoscine hydrobromide patches (Scopoderm 1.5mg Patch or Scopoderm TTS Patch): risk of anticholinergic side effects including hyperthermia.2023.https:\/\/www.gov.uk\/drug-safety-update\/hyoscine-hydrobromide-patches-scopoderm-1-dot-5mg-patch-or-scopoderm-tts-patch-risk-of-anticholinergic-side-effects-including-hyperthermia","DOI":"10.1007\/s40278-023-44165-2"},{"key":"e_1_2_11_139_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2024.102886"},{"key":"e_1_2_11_140_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra011089"},{"key":"e_1_2_11_141_1","doi-asserted-by":"publisher","DOI":"10.1080\/15563650.2022.2088378"},{"key":"e_1_2_11_142_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00228\u2010023\u201003487\u20103"},{"key":"e_1_2_11_143_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1528\u20101157.2003.40702.x"},{"key":"e_1_2_11_144_1","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp\u20102018\u20100039"},{"key":"e_1_2_11_145_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.forsciint.2013.03.021"},{"issue":"9","key":"e_1_2_11_146_1","first-page":"724","article-title":"Seasonal variation in plasma levels of lithium in the Indian population: is there a need to modify the dose?","volume":"49","author":"Medhi B","year":"2008","journal-title":"Singapore Med J"},{"key":"e_1_2_11_147_1","doi-asserted-by":"publisher","DOI":"10.1016\/s0165\u20101781(02)00130\u20100"},{"key":"e_1_2_11_148_1","doi-asserted-by":"publisher","DOI":"10.3109\/10401239509149019"},{"key":"e_1_2_11_149_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.smrv.2018.07.007"},{"key":"e_1_2_11_150_1","volume-title":"Contribution of Working Group I to the sixth assessment report of the IPCC","author":"Intergovernmental Panel on Climate Change (IPCC)","year":"2021"},{"key":"e_1_2_11_151_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467\u2010020\u201016970\u20107"},{"key":"e_1_2_11_152_1","unstructured":"US Environmental Protection Agency (EPA).Climate change indicators: heat waves. Published June2024. Accessed April 11 2025.https:\/\/www.epa.gov\/climate-indicators\/climate-change-indicators-heat-waves"},{"key":"e_1_2_11_153_1","unstructured":"ESOTC. Extreme weather and human health.Copernicus. Published April2024. Accessed April 11 2025.https:\/\/climate.copernicus.eu\/esotc\/2023\/extreme-weather-and-human-health"},{"key":"e_1_2_11_154_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2022.09.018"},{"key":"e_1_2_11_155_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healthplace.2018.08.017"},{"key":"e_1_2_11_156_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gloenvcha.2014.04.014"},{"key":"e_1_2_11_157_1","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.121.000994"},{"key":"e_1_2_11_158_1","volume-title":"Working Group I contribution to the sixth assessment report of the Intergovernmental Panel on Climate Change","author":"IPCC. Intergovernmental Panel on Climate Change","year":"2021"},{"key":"e_1_2_11_159_1","doi-asserted-by":"publisher","DOI":"10.24926\/iip.v12i2.3822"},{"key":"e_1_2_11_160_1","doi-asserted-by":"publisher","DOI":"10.1177\/014107680409700706"},{"key":"e_1_2_11_161_1","unstructured":"Lancet countdown:Tracking progress on health and climate change2024. Accessed November 21 2024."},{"key":"e_1_2_11_162_1","unstructured":"WHO (World Health Organisation).2024Health at COP28. Climate change and health. Accessed November 21 2024."},{"key":"e_1_2_11_163_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140\u20106736(24)01822\u20101"}],"container-title":["British Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bcp.70108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T07:14:28Z","timestamp":1753773268000},"score":1,"resource":{"primary":{"URL":"https:\/\/bpspubs.onlinelibrary.wiley.com\/doi\/10.1002\/bcp.70108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,27]]},"references-count":162,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10.1002\/bcp.70108"],"URL":"https:\/\/doi.org\/10.1002\/bcp.70108","archive":["Portico"],"relation":{},"ISSN":["0306-5251","1365-2125"],"issn-type":[{"value":"0306-5251","type":"print"},{"value":"1365-2125","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,27]]}}}